Genoil Inc. Files April 2025 6-K Report
Ticker: GNOLF · Form: 6-K · Filed: Apr 24, 2025 · CIK: 1261002
Sentiment: neutral
Topics: sec-filing, 6-k, routine-report
TL;DR
Genoil Inc. filed its April 6-K, confirming its status and NYC HQ.
AI Summary
Genoil Inc. filed a Form 6-K on April 24, 2025, reporting for the month of April 2025. The company, incorporated in New York, has its principal executive offices at One Rockefeller Plaza, 11th Floor, New York, NY 10020. Genoil Inc. is a foreign private issuer and files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and the market regarding Genoil Inc.'s status as a foreign private issuer. It confirms their reporting obligations and principal business location.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new financial information or significant operational updates.
Key Players & Entities
- GENOIL INC (company) — Filer
- One Rockefeller Plaza, 11th Floor, New York, NY 10020 (location) — Principal executive office address
- 20250424 (date) — Filing date
- April 2025 (date) — Reporting period
FAQ
What is the filing type and date?
The filing type is a Form 6-K, filed on April 24, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at One Rockefeller Plaza, 11th Floor, New York, NY 10020.
Does Genoil Inc. file annual reports under Form 20-F or 40-F?
Genoil Inc. files annual reports under cover of Form 20-F.
Is Genoil Inc. submitting this Form 6-K in paper format?
The filing does not indicate that the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
Is Genoil Inc. furnishing information to the Commission pursuant to Rule 12g3-2(b)?
The filing indicates 'No' for whether the registrant is furnishing information to the Commission pursuant to Rule 12g3-2(b).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 24, 2025 regarding GENOIL INC (GNOLF).